| 1 |
Merion RM, Goodrich NP, Feng s. How can we define expanded criteria for liver donors？[J]. J Hepatol, 2006, 45(4): 484-488.
|
| 2 |
Chouchani ET, Pell VR, Gaude E, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS[J]. Nature, 2014, 515(7527): 431-435.
|
| 3 |
Sibulesky L, Li M, Hansen RN, et al. Impact of cold ischemia time on outcomes of liver transplantation: a single center experience[J]. Ann Transplant, 2016, 21: 145-151.
|
| 4 |
Stahl JE, Kreke JE, Malek FA, et al. Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis[J]. PLoS One, 2008, 3(6): e2468.
|
| 5 |
St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion[J]. Lancet, 2002, 359(9306): 604-613.
|
| 6 |
Deshpande R, Heaton N. Can non-heart-beating donors replace cadaveric heart-beating liver donors？[J]. J Hepatol, 2006, 45(4): 499-503.
|
| 7 |
Dutkowski P, de Rougemont O, Clavien PA. Machine perfusion for 'marginal’ liver grafts[J]. Am J Transplant, 2008, 8(5): 917-924.
|
| 8 |
Starzl TE, Groth CG, Brettschneider L, et al. Extended survival in 3 cases of orthotopic homotransplantation of the human liver[J]. Surgery, 1968, 63(4): 549-563.
|
| 9 |
Butler AJ, Rees MA, Wight DG, et al. Successful extracorporeal porcine liver perfusion for 72 hr[J]. Transplantation, 2002, 73(8): 1212-1218.
|
| 10 |
Vajdová K, Smreková R, Mislanová C, et al. Cold-preservation-induced sensitivity of rat hepatocyte function to rewarming injury and its prevention by short-term reperfusion[J]. Hepatology, 2000, 32(2): 289-296.
|
| 11 |
Uemura T, Randall HB, Sanchez EQ, et al. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience[J]. Liver Transpl, 2007, 13(2): 227-233.
|
| 12 |
Belzer FO, Ashby BS, Gulyassy PF, et al. Successful seventeen-hour preservation and transplantation of human-cadaver kidney[J]. N Engl J Med, 1968, 278(11): 608-610.
|
| 13 |
Vekemans K, Liu Q, Pirenne J, et al. Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation[J]. Anat Rec (Hoboken), 2008, 291(6): 735-740.
|
| 14 |
Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557 (7703): 50-56.
|
| 15 |
Brockmann J, Reddy S, Coussios C, et al. Normothermic perfusion: a new paradigm for organ preservation[J]. Ann Surg, 2009, 250(1): 1-6.
|
| 16 |
Jochmans I, Moers C, Smits JM, et al. Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial[J]. Ann Surg, 2010, 252(5): 756-764.
|
| 17 |
Fondevila C, Hessheimer AJ, Maathuis MH, et al. Hypothermic oxygenated machine perfusion in porcine donation after circulatory determination of death liver transplant[J]. Transplantation, 2012. 94(1): 22-29.
|
| 18 |
Jamieson RW, Friend PJ. Organ reperfusion and preservation[J]. Front Biosci, 2008，13: 221-235.
|
| 19 |
Schlegel A, Kron P, Dutkowski P. Hypothermic machine perfusion in liver transplantation[J]. Curr Opin Organ Transplant, 2016, 21(3): 308-314.
|
| 20 |
de Meijer VE, Fujiyoshi M, Porte RJ. Ex situ machine perfusion strategies in liver transplantation[J]. J Hepatol, 2019, 70(1): 203-205.
|
| 21 |
Henry SD, Nachber E, Tulipan J, et a1. Hypothemlic machine preservation reduces nlolecular nlarkers of ischemia/repeffusion injury in human liver transplantation[J]. Am J Transplant, 2012, 12(9): 2477-2486.
|
| 22 |
Compagnon P, Levesque E, Hentati H, et al. An oxygenated and transportable machine perfusion system fully rescues liver grafts exposed to lethal ischemic damage in a pig model of DCD liver transplantation[J]. Transplantation, 2017, 101(7): e205-e213.
|
| 23 |
Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series[J]. Am J Transplant, 2010, 10(2): 372-381.
|
| 24 |
Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers[J]. Am J Transplant, 2015, 15(1): 161-169.
|
| 25 |
Zhang Y, Zhang Y, Zhang M, et al. Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis[J]. Medicine (Baltimore), 2019, 98(23): e16033.
|
| 26 |
Kron P, Schlegel A, Mancina L, et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans[J]. J Hepatol, 2017，68(1): 82-91.
|
| 27 |
Schlegel A, Muller X, Kalisvaart M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019, 70(1): 50-57.
|
| 28 |
Van Rijn R, Karimian N, Matton APM, et al. First clinical series of end-ischemic hypothermic oxygenated machine perfusion via hepatic artery and portal vein in donation after circulatory death liver transplantation[J]. Transplantation, 2015, 99(Supp l): 86.
|
| 29 |
van Rijn R, Karimian N, Matton APM, et al. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death[J]. Br J Surg, 2017, 104(7): 907-917.
|
| 30 |
van Rijn R, van Leeuwen OB, Matton APM, et al. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers[J]. Liver Transpl, 2018, 24(5): 655-664.
|
| 31 |
Dutkowski P, Schlegel A, de Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death[J]. J Hepatol, 2014, 60(4): 765-772.
|
| 32 |
Fontes P, Lopez R, van der Plaats A, et al. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions[J]. Am J Transplant, 2015, 15(2): 381-394.
|
| 33 |
Bruinsma BG, Yeh H, Ozer S, et al. Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation[J]. Am J Transplant, 2014, 14(6): 1400-1409.
|
| 34 |
Ravikumar R, Jassem W, Mergental H, et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial[J]. Am J Transplant, 2016, 16(6): 1779-1787.
|
| 35 |
Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557(7703): 50-56.
|
| 36 |
Bral M, Gala-Lopez B, Bigam D, et al. Preliminary single-center Canadian experience of human normothermic ex vivo liver perfusion: results of a clinical trial[J]. Am J Transplant, 2017, 17(4): 1071-1080.
|
| 37 |
Bral M, Dajani K, Leon Izquierdo D, et al. A back-to-base experience of human normothermic ex situ liver perfusion: Does the chill kill？[J]. Liver Transpl, 2019, 25(6): 848-858.
|
| 38 |
Attia M, Silva MA, Mirza DF. The marginal liver donor-an update[J]. Transpl Int, 2008, 21(8): 713-724.
|
| 39 |
Verhoeven CJ, Farid WR, de Jonge J, et al. Biomarkers to assess graft quality during conventional and machine preservation in liver transplantation[J]. J Hepatol, 2014, 61(3): 672-684.
|
| 40 |
Watson CJ, Kosmoliaptis V, Pley C, et al. Observations on the ex situ perfusion of livers for transplantation[J]. Am J Transplant, 2018, 18(8): 2005-2020.
|
| 41 |
Guarrera JV, Henry SD, Chen SW, et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results[J]. J Surg Res, 2011, 167(2): e365-e373.
|
| 42 |
Monbaliu D, Liu Q, Libbrecht L, et al. Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers[J]. Liver Transpl, 2012, 18(12): 1495-1507.
|
| 43 |
Matton APM, de Vries Y, Burlage LC, et al. Biliary bicarbonate, pH and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers[J]. Transplantation, 2019, 103(7): 1405-1413.
|
| 44 |
Eshmuminov D, Becker D, Bautista Borrego L, et al. An integrated perfusion machine preserves injured human livers for 1 week[J]. Nat Biotechnol, 2020, 38(2): 189-198.
|
| 45 |
Bessems M, Doorschodt BM, Kolkert JL, et al. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation[J]. Liver Transpl, 2007, 13(4): 497-504.
|
| 46 |
Vairetti M, Ferrigno A, Carlucci F, et al. Subnormothermic machine perfusion protects steatotic livers against preservation injury: a potential for donor pool increase？[J]. Liver Transpl, 2009, 15(1): 20-29.
|
| 47 |
Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo[J]. Metab Eng, 2009, 11(4-5): 274-283.
|
| 48 |
Boteon YL, Attard J, Boteon APCS, et al. Manipulation of lipid metabolism during normothermic machine perfusion: effect of defatting therapies on donor liver functional recovery[J]. Liver Transpl, 2019, 25(7): 1007-1022.
|
| 49 |
Bishawi M, Roan JN, Milano CA, et al. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy[J]. Sci Rep, 2019, 9(1): 8029.
|
| 50 |
Machuca TN, Cypel M, Bonato R, et al. Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model[J]. Hum Gene Ther, 2017，28: 757-765.
|
| 51 |
Ichim TE, Li MU, Qian H, et al. RNA interference: a potent tool for gene-specific therapeutics[J]. Am J Transplant, 2004, 4(8): 1227-1236.
|
| 52 |
Gillooly AR, Perry J, Martins PN. First report of siRNA uptake (for RNA Interference) during ex vivo hypothermic and normothermic liver machine perfusion [J]. Transplantation, 2019, 103(3): e56-e57.
|
| 53 |
Goldaracena N, Spetzler VN, Echeverri J, et al. Inducing hepatitis C virus resistance after pig liver transplantation-a proof of concept of liver graft modification using warm ex vivo perfusion[J]. Am J Transplant, 2017, 17(4): 970-978.
|
| 54 |
Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications[J]. Nat Rev Mol Cell Biol, 2019, 20(8): 490-507.
|
| 55 |
Verstegen MMA, Mezzanotte L, Ridwan RY, et al. First report on ex vivo delivery of paracrine active human mesenchymal stromal cells to liver grafts during machine perfusion[J]. Transplantation, 2020, 104(1): e5-e7.
|